Immuron Limited (NASDAQ: IMRN)
61 بار بازدید -
2 ماه پیش
-
Immuron Limited (NASDAQ: IMRN), is
Immuron Limited (NASDAQ: IMRN), is a biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
Keynote speaker: Steve Lydeamore, CEO
Keynote speaker: Steve Lydeamore, CEO
2 ماه پیش
در تاریخ 1403/03/24 منتشر شده
است.
61
بـار بازدید شده